Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐s...
Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease.
Methods
In order to assess the mechanism of DFO, determine its ability to improve memory from baseline in th...
Alternative Titles
Full title
Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ddb5a9d4b46347c0abe5269c4f0e207b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddb5a9d4b46347c0abe5269c4f0e207b
Other Identifiers
ISSN
2162-3279
E-ISSN
2162-3279
DOI
10.1002/brb3.1536
